Literature DB >> 10954889

Identification of the glycoprotein 41(TM) cytoplasmic tail domains of human immunodeficiency virus type 1 that interact with Pr55Gag particles.

C Hourioux1, D Brand, P Y Sizaret, F Lemiale, S Lebigot, F Barin, P Roingeard.   

Abstract

We investigated the protein/protein interactions that occur during human immunodeficiency virus (HIV-1) budding. We evaluated the binding to Pr55Gag particles of peptides mapping to the cytoplasmic tail of gp41TM and of host-cell proteins, in a cell-free, in vitro assay. Host-cell proteins and irrelevant viral envelope peptides did not bind. Peptides corresponding to a large central domain of the gp41TM cytoplasmic tail (93 residues) bound to Pr55Gag particles. This demonstrates that a Gag/Env interaction is responsible for the specific incorporation of the Env glycoprotein into nascent HIV-1 virions, and defines more accurately the gp41TM domain involved in this interaction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10954889     DOI: 10.1089/088922200414983

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  24 in total

1.  Endogenous virus and hepatitis C virus-like particle budding in BHK-21 cells.

Authors:  Emmanuelle Blanchard; Denys Brand; Philippe Roingeard
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

2.  Enhanced central nervous system transduction with lentiviral vectors pseudotyped with RVG/HIV-1gp41 chimeric envelope glycoproteins.

Authors:  Antonio Trabalza; Ioanna Eleftheriadou; Argyro Sgourou; Ting-Yi Liao; Petros Patsali; Heyne Lee; Nicholas D Mazarakis
Journal:  J Virol       Date:  2013-12-26       Impact factor: 5.103

3.  Membrane structure correlates to function of LLP2 on the cytoplasmic tail of HIV-1 gp41 protein.

Authors:  Alexander L Boscia; Kiyotaka Akabori; Zachary Benamram; Jonathan A Michel; Michael S Jablin; Jonathan D Steckbeck; Ronald C Montelaro; John F Nagle; Stephanie Tristram-Nagle
Journal:  Biophys J       Date:  2013-08-06       Impact factor: 4.033

4.  Hepatitis C virus-like particle morphogenesis.

Authors:  Emmanuelle Blanchard; Denys Brand; Sylvie Trassard; Alain Goudeau; Philippe Roingeard
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

5.  Amino acid residues in the cytoplasmic domain of the Mason-Pfizer monkey virus glycoprotein critical for its incorporation into virions.

Authors:  Chisu Song; Keith Micoli; Helena Bauerova; Iva Pichova; Eric Hunter
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

6.  Functional roles of equine infectious anemia virus Gag p9 in viral budding and infection.

Authors:  C Chen; F Li; R C Montelaro
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

7.  Analysis of HIV-1 Matrix-Envelope Cytoplasmic Tail Interactions.

Authors:  Ayna Alfadhli; August O Staubus; Philip R Tedbury; Mariia Novikova; Eric O Freed; Eric Barklis
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

8.  Effect of extension of the cytoplasmic domain of human immunodeficiency type 1 virus transmembrane protein gp41 on virus replication.

Authors:  Woan-Eng Chan; Ya-Lin Wang; Hui-Hua Lin; Steve S-L Chen
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

9.  Matrix and envelope coevolution revealed in a patient monitored since primary infection with human immunodeficiency virus type 1.

Authors:  Elodie Beaumont; Daniela Vendrame; Bernard Verrier; Emmanuelle Roch; François Biron; Françis Barin; Fabrizio Mammano; Denys Brand
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

10.  Evidence that Gag facilitates HIV-1 envelope association both in GPI-enriched plasma membrane and detergent resistant membranes and facilitates envelope incorporation onto virions in primary CD4+ T cells.

Authors:  Ajit Patil; Archana Gautam; Jayanta Bhattacharya
Journal:  Virol J       Date:  2010-01-08       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.